Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Annemarie Kline"'
Autor:
Mao Hu, Hui Lee Wong, Yuhui Feng, Patricia C. Lloyd, Elizabeth R. Smith, Kandace L. Amend, Annemarie Kline, Daniel C. Beachler, Joann F. Gruber, Mahasweta Mitra, John D. Seeger, Charlalynn Harris, Alex Secora, Joyce Obidi, Jing Wang, Jennifer Song, Cheryl N. McMahill-Walraven, Christian Reich, Rowan McEvoy, Rose Do, Yoganand Chillarige, Robin Clifford, Danielle D. Cooper, Azadeh Shoaibi, Richard Forshee, Steven A. Anderson
Publikováno v:
JAMA Pediatrics.
ImportanceActive monitoring of health outcomes after COVID-19 vaccination offers early detection of rare outcomes that may not be identified in prelicensure trials.ObjectiveTo conduct near–real-time monitoring of health outcomes following BNT162b2
Validation of diagnosis codes to identify hospitalized COVID ‐19 patients in health care claims data
Autor:
Sheryl A. Kluberg, Laura Hou, Sarah K. Dutcher, Monisha Billings, Brian Kit, Sengwee Toh, Sascha Dublin, Kevin Haynes, Annemarie Kline, Mahesh Maiyani, Pamala A. Pawloski, Eric S. Watson, Noelle M. Cocoros
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:476-480
Health plan claims may provide complete longitudinal data for timely, real-world population-level COVID-19 assessment. However, these data often lack laboratory results, the standard for COVID-19 diagnosis.We assessed the validity of ICD-10-CM diagno
Autor:
Mao Hu, Hui Lee Wong, Yuhui Feng, Patricia C. Lloyd, Elizabeth R. Smith, Kandace L. Amend, Annemarie Kline, Daniel C. Beachler, Joann F. Gruber, Mahasweta Mitra, John D. Seeger, Charlalynn Harris, Alex Secora, Joyce Obidi, Jing Wang, Jennifer Song, Cheryl N. McMahill-Walraven, Christian Reich, Rowan McEvoy, Rose Do, Yoganand Chillarige, Robin Clifford, Danielle D Cooper, Azadeh Shoaibi, Richard Forshee, Steven A. Anderson
ImportanceActive monitoring of health outcomes following COVID-19 vaccination offers early detection of rare outcomes that may not be identified in pre-licensure trials.ObjectiveTo conduct near-real time monitoring of health outcomes following BNT162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66234f2d329803a45b6a6553863e73ea
https://doi.org/10.1101/2022.10.28.22281532
https://doi.org/10.1101/2022.10.28.22281532
Autor:
Huifeng Yun, Aaron B. Mendelsohn, Katelyn J. King, Cynthia Holmes, Annemarie Kline, Charles E. Barr, Jie Zhang, Jeffrey S. Brown, Catherine M Lockhart, James Marshall, Kai Yeung, James Kenney, Cara L. McDermott, Kevin Haynes, John Barron
Publikováno v:
Pharmacoepidemiology and Drug Safety. 29:778-785
Purpose To assess the capture of biologics (originator and biosimilar) in the Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Distributed Research Network (DRN), with a focus on medical claim National Drug Code (NDC), a new data